Organogenesis Holdings Inc. (ORGO) Revenue History
Organogenesis Holdings Inc. (ORGO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $138.73M |
| 2017-12-31 | $198.51M |
| 2018-12-31 | $193.45M |
| 2019-12-31 | $260.98M |
| 2020-12-31 | $338.30M |
| 2021-12-31 | $467.36M |
| 2022-12-31 | $450.89M |
| 2023-12-31 | $433.14M |
| 2024-12-31 | $482.04M |
| 2025-12-31 | $564.17M |
How ORGO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
| HROW | Harrow Inc Com | $272.30M |
| ARVN | Arvinas Inc. | $262.60M |
| AKBA | Akebia Therapeutics Inc. | $236.20M |
| VNDA | Vanda Pharmaceuticals Inc. | $216.10M |
These are five companies in the same sector as ORGO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Organogenesis Holdings Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("ORGO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ORGO | $1.81 | -1.63% | 0.38M |
| 3 | ||||
| 4 | ||||
| 5 |